Hester Biosciences Limited Asset Resilience Ratio

Latest as of September 2025: 4.41%

Hester Biosciences Limited asset resilience ratio. Hester Biosciences Limited (HESTERBIO) has an Asset Resilience Ratio of 4.41% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hester Biosciences Limited (HESTERBIO) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs298.06 Million

≈ $3.22 Million USD Cash + Short-term Investments

Total Assets

Rs6.75 Billion

≈ $73.02 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Hester Biosciences Limited (2016–2025)

Asset resilience ratio of Hester Biosciences Limited from 2016 to 2025. This chart shows how Hester Biosciences Limited's Asset Resilience Ratio has changed over time. Read total liabilities of Hester Biosciences Limited for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Hester Biosciences Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Hester Biosciences Limited balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs79.38 Million	1.18%
Short-term Investments	Rs218.68 Million	3.24%
Total Liquid Assets	Rs298.06 Million	4.41%

Asset Resilience Insights

Limited Liquidity: Hester Biosciences Limited maintains only 4.41% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Hester Biosciences Limited Industry Peers by Asset Resilience Ratio

Compare Hester Biosciences Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Hester Biosciences Limited Asset Resilience Ratio by Year (2016–2025)

Hester Biosciences Limited asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Hester Biosciences Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.19%	Rs12.54 Million ≈ $135.62K	Rs6.53 Billion ≈ $70.66 Million	-0.19pp
2024-03-31	0.39%	Rs25.56 Million ≈ $276.42K	Rs6.62 Billion ≈ $71.63 Million	-2.97pp
2023-03-31	3.35%	Rs183.07 Million ≈ $1.98 Million	Rs5.46 Billion ≈ $59.03 Million	+3.27pp
2022-03-31	0.08%	Rs4.53 Million ≈ $48.99K	Rs5.62 Billion ≈ $60.80 Million	+0.01pp
2021-03-31	0.07%	Rs2.93 Million ≈ $31.69K	Rs4.11 Billion ≈ $44.45 Million	-6.05pp
2020-03-31	6.12%	Rs235.31 Million ≈ $2.54 Million	Rs3.84 Billion ≈ $41.58 Million	-7.11pp
2019-03-31	13.23%	Rs396.25 Million ≈ $4.29 Million	Rs2.99 Billion ≈ $32.38 Million	+11.70pp
2018-03-31	1.54%	Rs37.51 Million ≈ $405.61K	Rs2.44 Billion ≈ $26.39 Million	+1.51pp
2017-03-31	0.02%	Rs478.82K ≈ $5.18K	Rs2.18 Billion ≈ $23.59 Million	+0.31pp
2016-03-31	-0.29%	Rs-5.26 Million ≈ $-56.89K	Rs1.84 Billion ≈ $19.93 Million	--

pp = percentage points

About Hester Biosciences Limited

NSE:HESTERBIO India Drug Manufacturers - Specialty & Generic

Market Cap

$212.70 Million

Rs19.67 Billion INR

Market Cap Rank

#16115 Global

#826 in India

Share Price

Rs2312.00

Change (1 day)

+2.21%

52-Week Range

Rs1259.10 - Rs2545.00

All Time High

Rs3204.96